4 years ago

Interaction between anti-cancer drug hydroxycarbamide and boron nitride nanotube: A long-range corrected DFT study

Interaction between anti-cancer drug hydroxycarbamide and boron nitride nanotube: A long-range corrected DFT study
An accurate long-range corrected density functional theory (CAM-B3LYP) is used to optimize hydroxycarbamide (HC) with pristine/Fe-doped boron nitride nanotubes (Fe-BNNTs). In order to investigate the more detailed mechanism of their interactions, Natural Bond Orbital (NBO), Quantum Theory of Atoms in Molecules (QTAIM), and Frontier Molecular Orbital (FMO) calculations are implemented. Weak interactions such as hydrogen bonds and Van der Waals’ dispersion are analyzed via the non-covalent interaction index (NCI) as well as the reduced density gradient (RDG) analyses. The molecular electrostatic potential and density of state spectra for all complexes are obtained. The local reactivity of the drug molecule is studied using the Fukui function. Adsorption energies in the gas phase and solution (via IEFPCM model) are also calculated. Based upon the results, all complexes are energetically favorable, especially in the aqueous phase. The calculated results showed that Fe doping in BNNT increases drug-nanotube interaction, especially in case Fe substitutes nitrogen atom.

Publisher URL: www.sciencedirect.com/science

DOI: S2210271X17303456

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.